Syntara Limited (ASX:SNT), a clinical-stage drug development company, is pleased to advise that a recording of today’s investor call discussing the SNT-5505 interim Phase 2 data is now available.
Share
Your question will be sent privately to Syntara Therapeutics. The company may choose to make this question public.
